DE
Upload

FNN: Martin Shkreli Appears at House Hearing on Drug Pricing, Refuses to Answer Questions

FOX 10 Phoenix 42,26842K
203,959

Transcript

The interactive transcript could not be loaded.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Feb 4, 2016

(AP) - Pharmaceutical chief Martin Shkreli has arrived at a hearing where U.S. lawmakers want to hear from about severe hikes for a drug sold by a company that he acquired.But it's unlikely the former CEO of Turing Pharmaceuticals will answer questions in his appearance Thursday before the House Oversight and Government Reform Committee. Shkreli, widely scorned for hiking the price of a long-established and potentially lifesaving drug by more than 5,000 percent, has said he's exercising his Fifth Amendment right against self-incrimination. The 32-year-old Shkreli faces separate criminal charges of securities fraud related to another drug company. Also going before lawmakers is the interim CEO of Canada's largest drugmaker, Valeant Pharmaceuticals. Both companies have sharply raised prices for drugs taken by patients with heart problems, AIDS, cancer and other conditions.

Advertisement
When autoplay is enabled, a suggested video will automatically play next.

Up next

to add this to Watch Later

Add to